Search Results 41-50 of 40798 for Two-phase

  1. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 In Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

    Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 In Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). Print ...

  2. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    The purpose of this two-phase study is to compare CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to ...

  3. Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 - Mayo Clinic

    A gene editing medication is one that changes a targeted gene forever. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

  4. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...

  5. Phase 2 Study of TAK-341 for Multiple System Atrophy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    About this study. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab ...

  7. A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer - Mayo Clinic

    A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients. Participation eligibility.

  8. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. Oncology (Medical) - Clinical trials

    The study will be performed in two phases: Phase I will be performed for ... Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of ...

  10. Hodgkin lymphoma (Hodgkin disease) - Stages - Mayo Clinic

    A stage 2 Hodgkin lymphoma involves two or more lymph node regions on the same side of the diaphragm. Stage 3 lymphoma. At stage 3, Hodgkin lymphoma ...